In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Andrés Cervantes examines the indications and impact of targeting the HER2 pathway in the treatment of metastatic gastric cancer.
Earn CME credit for related activities at elc.imedex.com
© 2017 Imedex, LLC.
20 июл 2017
